The post Fourteen Big Feminist Wins in 2025 appeared first on Ms. Magazine.

The post Ms. Magazine’s Top Feminists of 2025 appeared first on Ms. Magazine.

Yet despite the drug’s promise, its development has been repeatedly stymied by abortion opponents who fear wider availability would weaken their attempts to suppress abortion access. 

The result? Women are left in needless pain and subject to invasive and unnecessary surgical procedures like hysterectomies.

The post Sneak Peek: What’s in the Winter Issue of Ms.? Groundbreaking Reporting on Women’s Health and Power appeared first on Ms. Magazine.

For my final entry of the year, we thought it worthwhile to offer a snapshot—a year’s worth of reporting on the depth of damage this administration has wreaked on women’s health, with real-time Contrarian reporting noted.

The post A Very Bad Year for Women’s Health appeared first on Ms. Magazine.

“Let me just tell you, you are an obnoxious—a terrible, actually a terrible reporter."

"Yes, this work will break your heart. Some days, it will exhaust you, and still, you must continue, because here’s what the research ultimately shows: When younger people lead, democracy doesn’t just survive, it thrives.”

“We are initiated into a sisterhood. We’re in a sorority that none of us asked to join, but we all stand here today, stronger together, because our collective voice is powerful.” 

The post The Best and Worst Quotes of 2025, By and About Women appeared first on Ms. Magazine.

Without the extension, more and more ACA marketplace enrollees will drop their increasingly costly health insurance plans. This comes at a time when the ACA is more popular than ever—recent polls show that across the political spectrum, three quarters of voters support extending the tax credits.

Could the administration's latest attack on transgender young people be the administration’s way of deflecting attention from the disaster unfolding in real time for millions of families in need of healthcare?  

The post Congress Went on Recess. Americans Got Higher Healthcare Bills. appeared first on Ms. Magazine.

“Abortion bans don’t stop people from needing and pursuing essential abortion care,” said Alison Norris, M.D., Ph.D., professor at The Ohio State University’s College of Public Health and #WeCount co-chair.

Despite these increases, Ushma Upadhyay, professor and fellow #WeCount co-chair, warned that unwarranted attacks on telehealth abortion may restrict access in the future. “This care is under assault by abortion opponents’ relentless attacks on mifepristone and telehealth—even though medication abortion is backed by a 25-year track record of safety and gold-standard science, and research shows that telehealth abortion is just as safe and effective as in-person care.”  

The post Abortion Continues to Increase in 2025 as Telehealth Expands, Especially in States with Bans and Restrictions appeared first on Ms. Magazine.

Despite being awash in revenue, and serial reports of fraud, waste and illegal use of taxpayer funds, these antiabortion clinics are positioning to realize a long-term goal: to “replace” Planned Parenthood and Title X programs and secure federal taxpayer funds to advance an agenda that promotes childbirth and undermines evidence-based healthcare. 

As right-wing politicians decimate the reproductive health delivery system for low-income and uninsured Americans, the UPC industry is ramping up the narrative that their unregulated pregnancy clinics are the answer to the maternal healthcare deserts their policies have created. 

Most media observers are predicting the Court will rule for the crisis pregnancy center, First Choice. If it does, unregulated pregnancy clinics nationwide will be further emboldened to resist any state oversight, including of their medical services. A bold, innovative, multi-front action by reproductive justice advocates, public health professionals and pro-choice officials is the only way we ensure they can’t succeed. 

The post The Supreme Court Case That Could Shield Unregulated Pregnancy Clinics From Oversight appeared first on Ms. Magazine.

Joined by Florida, Texas Attorney General Ken Paxton filed the case on Dec. 9 in federal court in Wichita Falls. The two states argued in a 120-page complaint that the FDA did not properly evaluate mifepristone’s safety and effectiveness when approving the drug in 2000 and its subsequent generic versions. They also challenged the agency’s moves that expanded access to the pills, including the ability to dispense them by mail.

Abortion access advocates have blasted the lawsuit.

“If they succeed in restricting access to mifepristone, abortion access will be devastated across the country, even in states where abortion remains legal,” Shellie Hayes-McMahon, executive director of Planned Parenthood Advocates of Texas. “This lawsuit is not about safety or healthcare; it is about control. And nothing short of full control over our bodies will satisfy them.”

The post Texas and Florida Sue FDA in New Bid to Block Abortion Pill Access appeared first on Ms. Magazine.

Given the pivotal role of these medications in preserving abortion access, antiabortion policymakers and advocates are resorting to increasingly unscientific, unconventional tactics to spread mis- and disinformation about medication abortion and about mifepristone, one of two drugs used in most medication abortions in the United States.

In a disturbing new strategy, antiabortion policymakers are attempting to weaponize environmental laws and regulations, citing false claims that medication abortion pollutes U.S. waterways and drinking water.

The post No, Abortion Pills Aren’t Polluting U.S. Waterways appeared first on Ms. Magazine.